ENAVATE SCIENCES GP, LLC
Follow13F filer, CIK 1953107, New York, NY
ENAVATE SCIENCES GP, LLC reported $139,236,883 across 5 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-014094
- Period
- 2024-12-31
- Reported value
- $139M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001104659-25-014094, largest first. % of portfolio is the value over $139,236,883, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| UPBUPSTREAM BIO INC | 2,459,703 | $40.4M | 29.04% | Timeline | |||
| IMNMIMMUNOME INC | 3,478,261 | $36.9M | 26.53% | Timeline | |||
| ZBIOZENAS BIOPHARMA INC | 3,761,359 | $30.8M | 22.12% | Timeline | |||
| CAMPCAMP4 THERAPEUTICS CORP | 3,785,802 | $19.8M | 14.19% | Timeline | |||
| CMPXCOMPASS THERAPEUTICS INC | 7,788,150 | $11.3M | 8.11% | Timeline |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-25-014094 | base | 2025-02-14 | acceptance time not in the bulk data set |